| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3799041
[patent_doc_number] => 05827900
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-27
[patent_title] => 'Method and pharmaceutical preparations for reducing the activity of cells'
[patent_app_type] => 1
[patent_app_number] => 8/532263
[patent_app_country] => US
[patent_app_date] => 1995-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 4651
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/827/05827900.pdf
[firstpage_image] =>[orig_patent_app_number] => 532263
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/532263 | Method and pharmaceutical preparations for reducing the activity of cells | Sep 21, 1995 | Issued |
Array
(
[id] => 4368519
[patent_doc_number] => 06274601
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Methods of inhibiting ulcerative mucositis'
[patent_app_type] => 1
[patent_app_number] => 8/532960
[patent_app_country] => US
[patent_app_date] => 1995-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3659
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274601.pdf
[firstpage_image] =>[orig_patent_app_number] => 532960
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/532960 | Methods of inhibiting ulcerative mucositis | Sep 21, 1995 | Issued |
Array
(
[id] => 3726911
[patent_doc_number] => 05665360
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Method of treating peripheral neuropathies of the feet and legs'
[patent_app_type] => 1
[patent_app_number] => 8/528999
[patent_app_country] => US
[patent_app_date] => 1995-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1096
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665360.pdf
[firstpage_image] =>[orig_patent_app_number] => 528999
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/528999 | Method of treating peripheral neuropathies of the feet and legs | Sep 14, 1995 | Issued |
Array
(
[id] => 4089800
[patent_doc_number] => 06133278
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Use of quinone and hydroquinone derivatives for the treatment of cachexia'
[patent_app_type] => 1
[patent_app_number] => 8/528152
[patent_app_country] => US
[patent_app_date] => 1995-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4731
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133278.pdf
[firstpage_image] =>[orig_patent_app_number] => 528152
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/528152 | Use of quinone and hydroquinone derivatives for the treatment of cachexia | Sep 13, 1995 | Issued |
Array
(
[id] => 3506838
[patent_doc_number] => 05569667
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-29
[patent_title] => 'Treatment of prostate cancer'
[patent_app_type] => 1
[patent_app_number] => 8/524912
[patent_app_country] => US
[patent_app_date] => 1995-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2870
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/569/05569667.pdf
[firstpage_image] =>[orig_patent_app_number] => 524912
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/524912 | Treatment of prostate cancer | Sep 7, 1995 | Issued |
Array
(
[id] => 3793136
[patent_doc_number] => 05780452
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Antimalarial drug'
[patent_app_type] => 1
[patent_app_number] => 8/424493
[patent_app_country] => US
[patent_app_date] => 1995-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 1392
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780452.pdf
[firstpage_image] =>[orig_patent_app_number] => 424493
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424493 | Antimalarial drug | Sep 6, 1995 | Issued |
Array
(
[id] => 3689123
[patent_doc_number] => 05691341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Apoptosis regulating composition'
[patent_app_type] => 1
[patent_app_number] => 8/520478
[patent_app_country] => US
[patent_app_date] => 1995-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12915
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 660
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/691/05691341.pdf
[firstpage_image] =>[orig_patent_app_number] => 520478
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/520478 | Apoptosis regulating composition | Aug 28, 1995 | Issued |
| 08/516004 | COMPOSITION AND METHOD FOR TREATING PROSTATE CANCER | Aug 15, 1995 | Abandoned |
Array
(
[id] => 3617199
[patent_doc_number] => 05641485
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-24
[patent_title] => 'Caledothricins used in the treatment mycotic diseases'
[patent_app_type] => 1
[patent_app_number] => 8/514019
[patent_app_country] => US
[patent_app_date] => 1995-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 5287
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/641/05641485.pdf
[firstpage_image] =>[orig_patent_app_number] => 514019
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/514019 | Caledothricins used in the treatment mycotic diseases | Aug 10, 1995 | Issued |
Array
(
[id] => 3851606
[patent_doc_number] => 05767148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Synergistic therapeutic compositions comprising at least one ligand specific for RXRs at least one ligand specific for RAR-.alpha.'
[patent_app_type] => 1
[patent_app_number] => 8/507913
[patent_app_country] => US
[patent_app_date] => 1995-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3422
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767148.pdf
[firstpage_image] =>[orig_patent_app_number] => 507913
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/507913 | Synergistic therapeutic compositions comprising at least one ligand specific for RXRs at least one ligand specific for RAR-.alpha. | Jul 26, 1995 | Issued |
Array
(
[id] => 4023410
[patent_doc_number] => 05925669
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Carrier compositions for anti-neoplastic drugs'
[patent_app_type] => 1
[patent_app_number] => 8/503326
[patent_app_country] => US
[patent_app_date] => 1995-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5620
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925669.pdf
[firstpage_image] =>[orig_patent_app_number] => 503326
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/503326 | Carrier compositions for anti-neoplastic drugs | Jul 16, 1995 | Issued |
| 08/481352 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CANCEROUS DISEASES AND PROCESS FOR THEIR PREPARATION | Jul 5, 1995 | Abandoned |
Array
(
[id] => 3762344
[patent_doc_number] => 05852033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Methods of treatment using lamellarin-class alkaloids'
[patent_app_type] => 1
[patent_app_number] => 8/496465
[patent_app_country] => US
[patent_app_date] => 1995-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3131
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852033.pdf
[firstpage_image] =>[orig_patent_app_number] => 496465
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/496465 | Methods of treatment using lamellarin-class alkaloids | Jun 28, 1995 | Issued |
| 08/473094 | METHOD FOR TREATING A PATIENT HAVING PRECANCEROUS LESIONS WITH 4- PHENYLPHTHALAZINE DERIVATIVES | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4216597
[patent_doc_number] => 06110923
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity'
[patent_app_type] => 1
[patent_app_number] => 8/487329
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22744
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110923.pdf
[firstpage_image] =>[orig_patent_app_number] => 487329
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487329 | Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity | Jun 6, 1995 | Issued |
Array
(
[id] => 4371676
[patent_doc_number] => 06288111
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Combination cisplatin/tamoxifen therapy for human cancers'
[patent_app_type] => 1
[patent_app_number] => 8/484024
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 5746
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288111.pdf
[firstpage_image] =>[orig_patent_app_number] => 484024
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484024 | Combination cisplatin/tamoxifen therapy for human cancers | Jun 6, 1995 | Issued |
Array
(
[id] => 3869401
[patent_doc_number] => 05837709
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Use of castanospermine as an anti-inflammatory and immunosupressant agent'
[patent_app_type] => 1
[patent_app_number] => 8/482083
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 20
[patent_no_of_words] => 6219
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837709.pdf
[firstpage_image] =>[orig_patent_app_number] => 482083
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482083 | Use of castanospermine as an anti-inflammatory and immunosupressant agent | Jun 6, 1995 | Issued |
| 08/485471 | METHOD FOR TREATING A PATIENT HAVING PRECANCEROUS LESIONS WITH A COMBINATION OF PYRIMIDOPYRIMIDINE DERIVATIVES AND ESTERS AND AMIDES OF SUBSTITUTED INDENYL ACETIC ACIDS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4043851
[patent_doc_number] => 05874440
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/472854
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5764
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874440.pdf
[firstpage_image] =>[orig_patent_app_number] => 472854
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472854 | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives | Jun 6, 1995 | Issued |
Array
(
[id] => 3546338
[patent_doc_number] => 05547666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Antibiotic GE 2270 factors A.sub.1, A.sub.2, A.sub.3 and H'
[patent_app_type] => 1
[patent_app_number] => 8/485678
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8672
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 607
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547666.pdf
[firstpage_image] =>[orig_patent_app_number] => 485678
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485678 | Antibiotic GE 2270 factors A.sub.1, A.sub.2, A.sub.3 and H | Jun 6, 1995 | Issued |